medigraphic.com
ISSN 1025-0298 (Electronic)
ISSN 1025-028X (Print)

2019, Number 2

<< Back Next >>

VacciMonitor 2019; 28 (2)

Mycobacterium tuberculosis recombinant protein Rv2626c expressed in Streptomyces lividans. Physico-chemical and immunological characterization as potential vaccine antigen

King-Batsios EN, Tamargo-Santos B, Marrero-Trujillo G, Ariel-Espinosa L, Besada V, Zayas-Vignier C, Sierra-González VG

Language: English
References: 29
Page: 68-79
PDF size: 655.77 Kb.


ABSTRACT

Mycobacterium tuberculosis (Mtb) is a leading cause of death globally. Latent tuberculosis infection threatens 1.7 billion people. Mtb latency is mediated by a group of proteins, mainly coded by the Dormancy Safety Regulator (DosR). The protein Rv2626c is the strongest regulated member of this operon. Previous results, including ours, indicate a strong potential of Rv2626c as antigen in a new multiple tuberculosis vaccine. Objectives of this study were to purify the rRv2626c protein and characterize it physico-chemically and immunologically. The purified protein migrates as a sole band after a non-reductive PAGE-silver staining. Under reductive conditions, the dimer isoform appearing at 30.9 kDa prevails over the monomer 15.6 kDa. Mass spectrometry corroborates electrophoresis results regarding dimer molecular weight, of approximately 32 kDa. Six of its digested peptides matched those of HRP-1 protein (Rv2626c) of Mtb whereas 92.1% of its amino acid sequence contains three mutations and the addition of an amino acid. With respect to native Mtb protein, 12 of the 13 main epitopes are conserved. Antigenicity was corroborated in volunteers, the antibody responses were signifi cantly higher in a number of infected tuberculosis patients in comparison to healthy Mantoux negative donors as well as in mice immunized with reference Rv2626c, while the immune identification pattern was as expected. The purified protein was able to elicit strong immune response in mice and the resulting antibodies recognized the reference Rv2626c protein. Lastly, the productive specific yield of the Streptomyces lividans strain is sustainable. Taking these results altogether, corroborates our rRv2626c as a promising candidate as antigen for new tuberculosis vaccine formulations.


REFERENCES

  1. World Health Organization. Global Tuberculosis Report 2018. Geneva: WHO; 2018. Available from: http://www.who.int/tb/publications/global_report/en/.

  2. Schrager L, Olesen O, Vekemans J, Lewinsohn D, Shea J, Hanekom W, Drager N. Global Report on Tuberculosis Vaccines. Executive Summary. Geneva: WHO; 2018. Available from: http://www.stoptb.org/assets/documents/pdf.

  3. Glaziou P, Floyd K, Raviglione MC. Global Epidemiology of Tuberculosis. Semin Respir Crit Care Med 2018;39:271-85.

  4. Dockrell HM, Smith SG. What Have We Learnt about BCG Vaccination in the Last 20 Years? Front Immunol 2017;8:1134. doi: 10.3389/fimmu.2017.01134.

  5. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346(8986):1339-45.

  6. Aronson NE, Santosham M, Comstock GW. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004;291(17):2086-91.

  7. Rodrigues LC, Diwan VK, Wheeler JG. Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis. Int J Epidemiol 1993;22(6):1154-8.

  8. Suen SC, Bendavid E, Goldhaber-Fiebert JD. Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India. Int J Tuberc Lung Dis 2015;19:1115-24.

  9. Roupie V, Romano M, Zhang L, Korf H, Lin MY, Franken KL, et al. Immunogenicity of eight dormancy (DosR) regulon encoded proteins of Mycobacterium tuberculosis in DNA vaccinated and TB infected mice. Infect Immun 2007;75:941-9.

  10. Ayala JC, Pimienta E, Rodriguez C, Anné J, Vallín C, Milanés MT, et al. Use of Strep-tag II for rapid detection and purifi cation of Mycobacterium tuberculosis recombinant antigens secreted by Streptomyces lividans. J Microbiol Methods 2013;94:192-8.

  11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.

  12. González LJ, Castellanos-Serra L, Badock V, Díaz M, Moro A, Perea S, et al. Identification of nuclear proteins of small cell lung cancer cell line H82: An improved procedure for the analysis of silver-stained proteins. Electrophoresis 2003;24:237-52.

  13. Kerényi L, Gallyas F. A highly sensitive method for demonstrating proteins in electrophoretic, immunoelectrophoretic and immunodiffusion preparations. Clin Chim Acta 1972;38(2):465-7.

  14. ICH. Q2A. International Conference on Harmonization of technical requirements for registration of pharmaceutical for human use. Validation of Analytical Procedures: Text and Methodology; Geneva: ICH Secretariat; 1996.

  15. ICH Q6B. International Conference on Harmonization of technical requirements for registration of pharmaceutical for human use. Specifications: Test procedures and acceptance criteria for biotechnological/biological products; Geneva: ICH Secretariat; 1999.

  16. ICH Q3A. International Conference on Harmonization of technical requirements for registration of pharmaceutical for human use. Impurities in New Drug Substances; Geneva: ICH Secretariat; 2008.

  17. Dass Ch. Fundamentals on Contemporary Mass Espectrometry. Hoboken (NJ): Wiley & Sons; 2007.

  18. Liebler D C. Introduction to Proteomics. Tools for the New Biology. Totowa (NJ): Springer; 2002.

  19. Ekman R, Silberring J, Westman-Brinkmalm A, Kraj A, editors. Mass Spectrometry. Instrumentation, Interpretation, and Applications.1st ed. Hoboken (NJ): Wiley & Sons; 2009.

  20. Watson TJ, Sparkman OD. Introduction to Mass Spectrometry. Instrumentation, Applications and Strategies for Data Interpretation.4th ed. London (UK): Wiley & Sons; 2007.

  21. Gross JH. Mass Espectrometry. A textbook. 2nd.Edition. Heidelberg (Germany): Springer; 2004.

  22. Sandoval W. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Analysis of Peptides. Curr Protoc Protein Sci 2014;77: 16.2.1-16.2.11. doi: 10.1002/0471140864.ps1602s77.

  23. Zhang G, Annan RS, Carr SA, Neubert TA. Overview of Peptide and Protein Analysis by Mass Spectrometry. Curr Protoc Mol Biol 2014;108:10.21.1-10.21.30. doi:10.1002/0471142727.mb1021s108.

  24. Proteome 2D-PAGE [Database on the Internet]. Berlín: The Max Planck Institute for Infection Biology. C1998 - [cited 2016 Jul 23]. Available from: http://web.mpiibberlin.mpg.de/cgi-bin/pdbs/2d-page/extern/spot.cgi.

  25. TB Database [Database on the Internet]. Boston (MA): Broad Institute and Stanford School of Medicine. C2010 - [cited 2016 Jul 23]. Available from: http://genome.tb.db.org/2016.

  26. Schmidt TG, Skerra A. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat Protoc 2007;2(6):1528-35.

  27. Pergande RM, Cologna MS. Isoelectric Point Separations of Peptides and Proteins. Proteomes 2017;5(1)E4. doi: 10.3390/proteomes5010004.

  28. Álvarez-Corrales NM. Immune responses against Mycobacterium Tuberculosis targets associated to latent and active Tuberculosis infection. [PhD Thesis] Stockholm (Sweden): Karolinska Institutet; 2014.

  29. Peña D, Rovetta AI, Hernández RE, Amiano NO, Pasquinelli V, Pellegrini JM et al. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérin-vaccinated Individuals. EBioMedicine (2015);2:884-90




2020     |     www.medigraphic.com